{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18500841", "DateCompleted": {"Year": "2008", "Month": "09", "Day": "12"}, "DateRevised": {"Year": "2008", "Month": "06", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2008", "Month": "05", "Day": "24"}], "Language": ["eng"], "ELocationID": ["10.1021/np800148w"], "Journal": {"ISSN": "1520-6025", "JournalIssue": {"Volume": "71", "Issue": "6", "PubDate": {"Year": "2008", "Month": "Jun"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides.", "Pagination": {"StartPage": "1037", "EndPage": "1045", "MedlinePgn": "1037-45"}, "Abstract": {"AbstractText": ["A reinvestigation of the CHCl 3-soluble extract from flowers of the Mexican medicinal arborescent morning glory, Ipomoea murucoides, through preparative-scale recycling HPLC, yielded six new pentasaccharides, murucoidins VI-XI (1- 6), as well as the known pescaprein III (7), stoloniferin I (8), and murucoidins I-V (9- 13). Their structures were characterized through the interpretation of their NMR spectroscopic and FABMS data. Compounds 1-6 were found to be macrolactones of three known glycosidic acids identified as simonic acids A and B, and operculinic acid A, with different fatty acids esterifying the same positions, C-2 on the second rhamnose unit and C-4 on the third rhamnose moiety. The lactonization site of the aglycone was placed at C-2 or C-3 of the second saccharide unit. The esterifying residues were composed of two short-chain fatty acids, 2-methylpropanoic and (2S)-methylbutyric acids, and two long-chain fatty acids, n-dodecanoic (lauric) acid and the new (8R)-(-)-8-hydroxydodecanoic acid. For the latter residue, its absolute configuration was determined by analysis of its Mosher ester derivatives. All members of the murucoidin series exerted a potentiation effect of norfloxacin against the NorA overexpressing Staphylococcus aureus strain SA-1199B by increasing the activity 4-fold (8 microg/mL from 32 microg/mL) at concentrations of 5-25 microg/mL. Stoloniferin I (8) enhanced norfloxacin activity 8-fold when incorporated at a concentration of 5 microg/mL. Therefore, this type of amphipathic oligosaccharide could be developed further to provide more potent inhibitors of this multidrug efflux pump."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacia, Facultad de Qu\u00edmica, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad Universitaria, Mexico City 04510 DF, Mexico."}], "Identifier": [], "LastName": "Ch\u00e9rigo", "ForeName": "Lilia", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pereda-Miranda", "ForeName": "Rogelio", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fragoso-Serrano", "ForeName": "Mabel", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jacobo-Herrera", "ForeName": "Nadia", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kaatz", "ForeName": "Glenn W", "Initials": "GW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gibbons", "ForeName": "Simon", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Fatty Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Transport Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Resins, Plant"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "Carbohydrate Sequence"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": [], "DescriptorName": "Drug Resistance, Multiple, Bacterial"}, {"QualifierName": ["chemistry", "isolation & purification"], "DescriptorName": "Fatty Acids"}, {"QualifierName": ["chemistry", "isolation & purification"], "DescriptorName": "Glycosides"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ipomoea"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Membrane Transport Proteins"}, {"QualifierName": [], "DescriptorName": "Mexico"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Nuclear Magnetic Resonance, Biomolecular"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "isolation & purification"], "DescriptorName": "Resins, Plant"}, {"QualifierName": ["drug effects", "genetics", "metabolism"], "DescriptorName": "Staphylococcus aureus"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "5", "Day": "27", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "9", "Day": "16", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "5", "Day": "27", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18500841", "10.1021/np800148w"]}}], "PubmedBookArticle": []}